Skip to main content

Tapering Suit

Six researchers at the University of California, San Diego, are suing the Ludwig Institute for Cancer Research for "tapering" their research funding, ScienceInsider reports.

It adds that the researchers — Don Cleveland, Arshad Desai, Richard Kolodner, Paul Mischel, Karen Oegema, and Bing Ren — say that Ludwig is reducing their funding as it prepares to close its San Diego branch. In their suit, which ScienceInsider has posted, the six allege that this is a breach of Ludwig's affiliation agreement with UCSD — Ludwig researchers are employed both by Ludwig and the host institution, in this case, UCSD. The suit alleges that by tapering funding, Ludwig is breaching its agreement to "provide future financial support for 'continuous, active conduct of medical research' towards a cure for cancer at UCSD."

Ludwig tells ScienceInsider that it is taking steps to close its San Diego branch but that "is honoring its contractual obligations" in doing so and says it will respond to the lawsuit's allegations "in due course."

The Scan

Not Kept "Clean and Sanitary"

A Food and Drug Administration inspection uncovered problems with cross contamination at an Emergent BioSolutions facility, the Wall Street Journal reports.

Resumption Recommendation Expected

The Washington Post reports that US officials are expected to give the go-ahead to resume using Johnson & Johnson's SARS-CoV-2 vaccine.

Canada's New Budget on Science

Science writes that Canada's new budget includes funding for the life sciences, but not as much as hoped for investigator-driven research.

Nature Papers Examine Single-Cell, Multi-Omic SARS-CoV-2 Response; Flatfish Sequences; More

In Nature this week: single-cell, multi-omics analysis provides insight into COVID-19 pathogenesis, evolution of flatfish, and more.